AUROBINDO PHARMA LTD. - 524804 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate in terms of Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018 for the quarter ended 31.12.2023.04-01-2024
04-01-2024
AUROBINDO PHARMA LTD. - 524804 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Submission of postal ballot voting results along with Scrutinizer''s report.27-12-2023
Aurobindo Pharma Gets U.S.FDA Nod For Generic Antifungal Injection
The approval by the U.S. Food & Drug Administration is for Posaconazole injection of 300 mg/16.7 mL (18 mg/mL), single-dose vial, Aurobindo Pharma said in a regulatory filing.27-12-2023
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release in connection with USFDA approval received by Eugia Pharma Specialities Limited, a wholly owned subsidiary of the Company.27-12-2023
Aurobindo Pharma shares trade lower after US FDA slaps 10 observations
The observations are procedural in nature and will be responded to within the stipulated time, while the plant is yet to start commercial operations, company said.26-12-2023
AUROBINDO PHARMA LTD. - 524804 - Closure of Trading Window
Intimation of closure of Trading Window from 1st January 2024 until 48 hours after the declaration of unaudited financial results for the quarter ending 31st December 2023.25-12-2023
AUROBINDO PHARMA LTD. - 524804 - Closure of Trading Window
Intimation of closure of Trading Window from 1st January 2024 until 48 hours after the declaration of unaudited financial results for the quarter ending 31st December 2023.25-12-2023
AUROBINDO PHARMA LTD. - 524804 - Closure of Trading Window
Intimation of closure of Trading Window from 1st January 2024 until 48 hours after the declaration of unaudited financial results for the quarter ending 31st December 2023.25-12-2023
AUROBINDO PHARMA LTD. - 524804 - Completion Of US FDA Pre-Approval Inspection (PAI) At Our New Injectable Facility Of Eugia US Manufacturing LLC, East Windsor, New Jersey, USA
Completion of USFDA Pre-approval Inspection at our new injectable facility of Eugia Manufacturing LLC, USA24-12-2023
Stock to buy today: Aurobindo Pharma(1,092.1)
Buy at current level, stop-loss at 1,055, liquidate at 1,12022-12-2023